Implied volatility isn’t just noise — it’s the heartbeat of the options market. In his latest YouTube video, Rick Orford ...

Nvidia Corporation recently announced a $100 billion investment in OpenAI, aiming to solidify a strategic partnership for next-generation AI infrastructure. Learn more about NVDA stock here.

SDOF IV will continue UTI Alternatives’ disciplined approach to private credit, leveraging structures and active monitoring ...

POET Technologies made progress in Malaysian production facilities, with a $500K order for optical engines. Check out a bull ...

For options traders, volatility often matters just as much as price direction. The problem? Tracking metrics like IV Rank, IV ...

Avtozma was FDA-approved in January 2025 to treat the same conditions as the reference product Actemra (tocilizumab).

The FDA has approved a subcutaneous (SC) induction regimen of guselkumab (Tremfya) for adults with moderately to severely ...

FDA approves Keytruda Qlex, a subcutaneous injection version of the widely used cancer therapy Keytruda Patients can now ...

IV Solution and Ketamine Centers of Chicago continues to demonstrate the transformative impact of its specialized mental health treatments through documented patient outcomes shared across multiple ...

The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as the reference product ACTEMRA® (tocilizumab) AVTOZMA is Celltrion's ...

BioRestore Introduces Accessible IV Therapy to Enhance Patient Wellness Programs NEWTOWN, CT, UNITED STATES, September 15, 2025 /EINPresswire / -- BioRestore, a leading Connecticut-based medical ...